Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
74.34
+2.12 (2.94%)
At close: Mar 23, 2026, 4:00 PM EDT
73.51
-0.83 (-1.12%)
After-hours: Mar 23, 2026, 7:57 PM EDT
Nektar Therapeutics Employees
Nektar Therapeutics had 61 employees as of December 31, 2024. The number of employees decreased by 76 or -55.47% compared to the previous year.
Employees
61
Change (1Y)
-76
Growth (1Y)
-55.47%
Revenue / Employee
$905,443
Profits / Employee
-$2,689,770
Market Cap
2.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 61 | -76 | -55.47% |
| Dec 31, 2023 | 137 | -79 | -36.57% |
| Dec 31, 2022 | 216 | -524 | -70.81% |
| Dec 31, 2021 | 740 | 22 | 3.06% |
| Dec 31, 2020 | 718 | -5 | -0.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptive Biotechnologies | 624 |
| Ascentage Pharma Group International | 605 |
| Galapagos NV | 558 |
| Wave Life Sciences | 317 |
| Syndax Pharmaceuticals | 298 |
| Celldex Therapeutics | 198 |
| Day One Biopharmaceuticals | 178 |
| Stoke Therapeutics | 170 |
NKTR News
- 3 days ago - Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting - PRNewsWire
- 10 days ago - Nektar Therapeutics (NKTR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 13 days ago - NEKTAR THERAPEUTICS (NKTR) INVESTOR ALERT Investors With Large Losses in Nektar Therapeutics Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 14 days ago - Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Nektar Therapeutics, (NKTR) - Newsfile Corp
- 17 days ago - Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 25 days ago - Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2025 on Thursday, March 12, 2026, After Close of U.S.-Based Financial Markets - PRNewsWire
- 27 days ago - Nektar Therapeutics to Participate in Two Investor Conferences in March - PRNewsWire